The AHA July 20 submitted comments on proposed Centers for Medicare & Medicaid Services regulations that would support state flexibility in Medicaid drug value-based purchasing arrangements and other changes to the Medicaid drug rebate program for fiscal year 2021.

“The AHA supports innovations in drug purchasing arrangements, so long as these arrangements preserve or enhance patient access to critical medications and result in lower drug costs,” AHA wrote. “As CMS continues to pursue an increase in VBP opportunity, we urge the agency to consider the appropriate balance that must be struck to make these arrangements work effectively for the Medicaid program as well as throughout the health care delivery system.”

AHA also urged the agency to extend the comment period beyond the current 30-day period to allow stakeholders’ thoughtful and careful consideration for assessing the implications of applying VBP arrangements for Medicaid drug coverage and purchasing.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services yesterday released guidance on an optional home health services benefit for Medicaid-eligible children…
Headline
The Centers for Medicare & Medicaid Services this week shared a suite of new resources that can be used to improve state and federal monitoring and…
Headline
Tax-exempt hospitals and health systems provided over $110 billion in community benefits in fiscal year 2019, almost nine times the value of their federal tax…
Headline
The Department of Health and Human Services today announced that states have an additional year to use American Rescue Plan funds for Medicaid…
Headline
The Centers for Medicare & Medicaid Services yesterday approved state plan amendments allowing California, Kentucky and Oregon to extend postpartum…
Blog
After two years on the front lines in the battle against this pandemic, hospitals and health systems have seen a dramatic rise in costs of labor, drugs,…